Seeking Alpha

Supernus Pharmaceuticals (SUPN): Q4 EPS of -$0.51 beats by $0.20. Revenue of $1.09M. (PR)

Supernus Pharmaceuticals (SUPN): Q4 EPS of -$0.51 beats by $0.20. Revenue of $1.09M. (PR)
Comments (1)
  • SUPN is a steal at this price....I see a target price of 10
    15 Mar 2013, 05:28 AM Reply Like
DJIA (DIA) S&P 500 (SPY)